Evidence level: C
如果一个人身上存在可测的”个体共振频率”,那么在讨论它能否预测疗效之前,必须先回答:这个数隔天再测还是同一个数吗?
正文
“共振频率”(Resonance Frequency,RF)在心率变异性生物反馈(HRVB)研究里是一个很具体的量:让受试者按不同呼吸率逐档呼吸(比如每分钟 5.0 到 7.0 次、每档 0.5 次),找出心血管振荡幅度最大的那个档位。这个数个体差异很大——有人峰在 4.5 次/分,有人到 6.5 次/分——所以”要不要逐人测”一直是这条技术路线的核心问题。
但一个更基础的问题经常被跳过:这个数本身稳不稳定? Capdevila 等人 2021 年在 Scientific Reports 给了一个相当泼冷水的答案:21 名受试者做测试-复测,66.7% 的人 RF 在两次之间变了,而且这种不稳定可能与平均心动周期(IBI)本身的变化有关。结论很直接:RF 不该被当作一个”终身属性”,每次训练前都应该现测现用(PMID 33863966)。这与更早期的乐观结论(间隔两周复测 r=0.73)形成了正面对照。
现在把这个基准问题搬到外气治疗师群体身上,就得到本文要问的三件事。第一,改变率:普通人的 RF 两次测定改变率约 2/3,那治疗师群体是更高还是更低?如果训练有素的呼吸-自主神经调控能力意味着”RF 更锚定”,改变率应当更低;如果发功状态本身伴随强烈的自主神经状态切换(有综述整理的实验报道发功时手掌红外辐射在 0.3 Hz 处强度变化可达 80%,磁场信号可高出基线约千倍量级,尽管这些结果的可靠性本身存争议),那么 RF 可能更”漂”——两种预测方向相反,恰好构成一个可判别的问题(PMID 15285273)。第二,”当下 RF” vs “历史 RF”:预测发功状态的生理同步指标时,用当天现测的 RF 校准,还是用档案里的历史 RF 校准,哪个预测力更强?Capdevila 的数据已经暗示”当下 RF”大概率胜出——最大心血管增益只出现在当次实测 RF 上,而不是固定 6 次/分。第三,测量通道:L1 证据网络里已有的四通道同体共振测量(心率、血压、血管张力、脉幅)显示共振频率与身高负相关、且跨 10 次训练稳定(PMID 16838124)——这是”稳定派”的重要证据,但它测的是健康人群的呼吸-心血管共振,不是治疗师、更不是发功状态,迁移过去是否成立完全是未知数。
用易学的语言说,这就是”气”的个体化测量遇到的第一道门槛:连常量都不是,就谈不上”调频”。如果治疗师的 RF 跨日漂移比普通人更厉害,那”某治疗师有固定频率特征”的说法就站不住;如果更稳定,才值得进入下一步——用 RF 变化预测发功状态。这正是科学精神的做法:先把测量对象的存在性和稳定性钉牢,再谈机制。
证据与局限
已验证: RF 存在显著个体差异;普通人两次测定 RF 改变率 66.7%(n=21,PMID 33863966);四通道共振测量在健康人群跨 10 次训练稳定(PMID 16838124)。
部分验证: 早期小样本(n=21,间隔两周)报告 RF 复测 r=0.73,与 33863966 的不稳定结论相互矛盾,样本都很小;外气相关物理信号测量(红外/磁场)有阳性报道但方法学争议大(PMID 15285273)。
待验证: 治疗师群体 RF 改变率与普通人的对照;”当下 RF”与”历史 RF”对发功状态预测力的头对头比较;发功状态是否伴随 RF 漂移本身。
相关阅读
L1 网络状态:该主题(治疗师个体共振频率的跨日/跨疗程稳定性)尚未进入 L1 对应网络——L1 中共振频率相关边全部为呼吸性 RF/HRV 方向(E-061 系),无外气治疗师这条边。
证据等级: C
参考文献: PMID 33863966, PMID 16838124, PMID 15285273
证据等级:A=有PubMed直接支撑,B=科学类比/间接证据,C=传统文化共识/初步探索
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
Are the therapist’s \”resonant frequencies\” stable? Cross-day retesting is the first unavoidable benchmark.
Evidence level: C
If an individual possesses a measurable “resonant frequency,” then before discussing whether it can predict therapeutic efficacy, one must first answer: does this value remain the same when re-tested the next day, or does it fluctuate?
Evidence Level A: Stability of Resonant Frequency Across Time
The stability of the individual resonant frequency across time constitutes the foundational evidence level for validating any predictive model of therapeutic efficacy. Without establishing temporal consistency, claims regarding frequency-based interventions lack empirical grounding.
Cross-Day Re-testing: The First Benchmark
Cross-day re-testing represents the primary benchmark in evaluating the reliability of frequency-based assessments. This process involves measuring the individual’s resonant frequency on consecutive days to determine whether the value remains constant or exhibits significant variation.
Methodology of Cross-Day Re-testing
The methodology for cross-day re-testing involves the following steps:
- Initial Measurement: Conduct the first measurement of the individual’s resonant frequency using established techniques.
- Rest Period: Allow an appropriate rest period between measurements to minimize immediate environmental influences.
- Second Measurement: Perform the second measurement of the resonant frequency on the following day under similar conditions.
- Comparison: Compare the two measurements to assess stability and identify any variations.
Statistical Analysis of Results
Statistical analysis of the results from cross-day re-testing provides critical insights into the reliability of the frequency-based assessment. This analysis typically includes:
- Mean and Variance: Calculate the mean value of the resonant frequency across both days and determine the variance to assess consistency.
- Correlation Coefficient: Compute the correlation coefficient between the two measurements to quantify the degree of linear relationship.
- Confidence Intervals: Establish confidence intervals around the mean value to provide a range within which the true resonant frequency likely lies.
Interpretation of Findings
The interpretation of findings from cross-day re-testing yields several key conclusions:
- Stable Frequency: If the resonant frequency remains consistent across both days, this indicates a stable individual characteristic that can be reliably used for predictive modeling.
- Variable Frequency: If the resonant frequency shows significant variation, this suggests that external factors or measurement inconsistencies may be influencing the results, necessitating further investigation.
- Trend Analysis: Analyze any trends observed in the frequency values over time to identify patterns that could inform future therapeutic interventions.
Implications for Therapeutic Practice
The implications of cross-day re-testing for therapeutic practice are profound and multifaceted:
- Predictive Accuracy: A stable resonant frequency enhances the accuracy of predictions regarding therapeutic outcomes, allowing for more targeted interventions.
- Individualized Treatment: Understanding the variability in resonant frequencies enables practitioners to tailor treatments to each individual’s unique characteristics.
- Monitoring Progress: Regular re-testing provides a means of monitoring progress and adjusting treatment plans accordingly.
Conclusion
In conclusion, cross-day re-testing serves as the essential first benchmark in validating the stability of an individual’s resonant frequency. This process is crucial for establishing the reliability of frequency-based assessments and informing effective therapeutic strategies. By rigorously applying statistical analysis and interpreting findings with care, practitioners can enhance the precision of their predictions and optimize treatment outcomes.
Body
“Resonance Frequency” (RF) is a specific metric in Heart Rate Variability Biofeedback (HRVB) research: subjects breathe at incrementally different rates (e.g., 5.0 to 7.0 breaths per minute, in steps of 0.5) to identify the rate yielding the largest cardiovascular oscillation amplitude. This value varies significantly between individuals—some peak at 4.5 breaths/min, others at 6.5 breaths/min—so whether to measure each person individually remains the core technical question in this approach.
A more fundamental issue is often overlooked: Is this number itself stable? Capdevila et al. (2021) provided a rather sobering answer in Scientific Reports: among 21 subjects undergoing test-retest, 66.7% showed a change in RF between the two sessions, and this instability may be linked to changes in the inter-beat interval (IBI) itself. The conclusion is direct: RF should not be treated as a “lifelong trait”; it must be measured immediately before each training session (PMID 33863966). This contrasts sharply with earlier optimistic findings (retest correlation r=0.73 over two weeks).
Translating this baseline question to the population of Qi practitioners yields three specific inquiries. First, the rate of change: ordinary individuals show an RF variation of about 2/3 between measurements; is the practitioner group higher or lower? If trained breath-autonomic regulation implies “RF is more anchored,” the variation should be smaller; if the Qi emission state itself involves strong autonomic state switching (a review reports infrared radiation from palms during Qi emission fluctuates by up to 80% at 0.3 Hz, and magnetic field signals can exceed baseline by orders of magnitude, though reliability of these results is debated), then RF might be more “drifting”—two opposing predictions, forming a discriminable question (PMID 15285273). Second, “current RF” vs. “historical RF”: when predicting physiological synchrony indicators of Qi emission, does calibrating with the day’s measured RF yield better prediction than using archived historical RF? Capdevila’s data already suggests “current RF” likely wins—maximum cardiovascular gain occurs only at the instantaneously measured RF, not at a fixed 6 breaths/min. Third, measurement channels: the four-channel same-body resonance measurement already in the L1 evidence network (heart rate, blood pressure, vascular tension, pulse amplitude) shows RF correlates negatively with height and remains stable across 10 training sessions (PMID 16838124)—this is key evidence for the “stability camp,” but it measures breath-cardiovascular resonance in healthy populations, not practitioners, nor Qi emission states; whether this transfers is entirely unknown.
In Yijing Studies terms, this represents the first threshold encountered in individualized measurement of Qi: even if it is not a constant, we cannot speak of “frequency tuning.” If practitioners’ RF drifts across days more than ordinary people, the claim that “a practitioner has a fixed frequency characteristic” collapses; only if it proves more stable does it warrant the next step—using RF variation to predict Qi emission states. This is precisely the scientific approach: first anchor the existence and stability of the measured object, then discuss mechanisms.
Evidence and Limitations
Verified: RF exhibits significant inter-individual variation; in the general population, the rate of change upon repeated measurement is 66.7% (n=21, PMID 33863966); four-channel resonance measurements demonstrate stability across ten training sessions in healthy subjects (PMID 16838124).
Partially Verified: Early small-sample studies (n=21, two-week interval) reported an RF retest correlation of r=0.73, contradicting the unstable conclusion of PMID 33863966; both samples were small. Positive reports exist for external air-related physical signal measurements (infrared/magnetic fields), though methodological controversy remains substantial (PMID 15285273).
Pending Verification: Comparison of RF change rates between therapist groups and the general population; head-to-head comparison of the predictive power of “current RF” versus “historical RF” on emission state; whether emission state is accompanied by RF drift itself.
Related Reading
- Individual resonance peak vs fixed 6 cycles/min
- Three protocols for resonance-frequency breathing training
- Research pool: Environment–life frequency interface
L1 Network Status: This topic (stability of the therapist’s individual resonance frequency across days and treatment cycles) has not yet entered the L1 corresponding network—in L1, all resonance-frequency-related edges are oriented toward respiratory RF/HRV (E-061 series), with no edge for the external-Qi therapist.
Evidence Level: C
References: PMID 33863966, PMID 16838124, PMID 15285273
Evidence level: A = direct PubMed support; B = scientific analogy/indirect evidence; C = traditional consensus/preliminary exploration.
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply